In a similar vein, patients with high CCR4-T expression (179, 50.6%) demonstrated markedly shorter OS (P < 0.001) and RFS (P = 0.039), whereas CCR4-I expression did not exhibit a statistically significant impact on HCC patient outcomes (Table 3). Here, CCR4 is linked to hepatocellular carcinoma.